Table 3.
Study A (n=302) | Study B (n=124) | |||
---|---|---|---|---|
ΔGFR (ml/min/1.73 m2) | −0.3 | [−2.1, 1.6] | −0.2 | [−1.9, 1.4] |
Δ Serum Creatinine (mg/dl) | −0.22 | [−0.36, −0.08] | −0.28 | [−0.82, 0.21] |
Δ eGFRcr (ml/min/1.73 m2) | +2.2 | [0.6, 3.9] | +0.8 | [−1.0, 2.6] |
Δ Serum Cystatin C (mg/l) | 0.02 | [−0.08, 0.13] | 0.10 | [−0.15, 0.26] |
Δ eGFRcys (ml/min/1.73 m2) | −0.4 | [−2.1, 0.9] | −0.3 | −1.5, 2.2] |
Differences between randomized groups (change in low protein diet group minus change in usual protein diet group in Study A; very low minus low protein diet group).
Change is defined as 24 mo-baseline. Changes in creatinine and cystatin C and eGFR measurements are adjusted for change in measured GFR.
All values are reported as mean and 95% CI. Values highlighted in boldface font are statistically significant with p<0.01